Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
Koninklijke Philips N.V. v. Google LLC, et al., Appeal No. 2019-1177 (Fed. Cir. Jan. 30, 2020)
In the Federal Circuit’s only precedential decision this week, the Court affirmed a PTAB finding that claims of a patent directed to downloading and streaming services were invalid as obvious. In doing so, the Court established precedent concerning the extent to which parties can rely on evidence of “general knowledge” in the art to fill claim limitations, and further reinforced that the PTAB may only institute review on grounds specifically pleaded in the Petition.
Streaming services previously had problems with delay because the entire file needed to get downloaded before it could play. In the alternative, two-way communications were required. The patent at issue purported to solve those problems by using multiple files that could play sequentially, and recited a system to effectuate that.
Google filed a petition for inter partes review based on two prior art references, SMIL 1.0 and Hua. Hua concerned “pipelining,” and was relied on to provide “general knowledge” in the art at the time. In its petition, Google advanced theories of anticipation by SMIL and obviousness over SMIL by itself—the latter theory was that the person of ordinary skill in the art would have thought to add “pipelining” to SMIL.
Read More.
Written by: Scott D. Eads and Nika Aldrich, Schwabe Williamson & Wyatt
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…